| Quarterly Financials | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 6 | 6 | 5 | 5 | 5 | 4 | 2 | 3 | 3 | 4 | 3 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| Expenses | 4 | 4 | 3 | 3 | 3 | 3 | 1 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
| EBITDA | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 17 % | 28 % | 29 % | 25 % | 23 % | 8 % | 24 % | 34 % | 28 % | 34 % | 38 % | 37 % | 39 % | 37 % | 38 % | 43 % | 27 % | 14 % | 17 % | 37 % | 34 % | 31 % | 34 % | 34 % | 36 % | 22 % | 23 % | 26 % | 26 % | 28 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 |
| Tax | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 1 | -0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| EPS in ₹ | 0.61 | 1.21 | 0.73 | 0.81 | 0.58 | -0.05 | 0.07 | 0.57 | 0.60 | 0.77 | 0.75 | 0.73 | 0.67 | 0.53 | 0.55 | 0.82 | 0.31 | -0.01 | 0.08 | 0.28 | 0.27 | 0.25 | 0.29 | 0.31 | 0.38 | 0.21 | 0.12 | 0.15 | 0.14 | 0.17 |
Tejnaksh Healthcare
Tejnaksh Healthcare
13.70
-0.97
(-6.61%)
Market Cap
27.83 Cr
PE Ratio
25.29
Volume
5,928.00
Day High - Low
14.79 - 13.70
52W High-Low
23.31 - 10.65
Key Fundamentals
Market Cap
27.83 Cr
EPS
0.61
PE Ratio
25.29
PB Ratio
1.10
Book Value
13.36
EBITDA
2.78
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
8.43
Debt to Equity
0.12
Actual
Company News
View All News
Tejnaksh Healthcare reported a 47% decline in consolidated net profit to ₹118.11 lakh for FY26. Revenue from operations dropped 16% to ₹1,078.69 lakh.
Tejnaksh Healthcare board meets May 30
May 20, 2026
May 20, 2026Tejnaksh Healthcare Limited will hold a board meeting on May 30, 2026, to consider audited financial results for Q4 and FY26. Trading window closed from March 27.
Tejnaksh Healthcare Q3FY26 Results AnnouncedFeb 07, 2026
Feb 07, 2026Tejnaksh Healthcare Limited reported Q3FY26 consolidated results with revenue of ₹261.62 lakhs and net profit of ₹28.82 lakhs for quarter ended December 31, 2025.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,545.90 | #1 25,902.33 | 50.51 | #1 2,762.90 | 8.15 | #1 510 | -14.98 | 47.28 | |
1,307.60 | 13,454.78 | 81.95 | 814.20 | 16.36 | 182 | 37.25 | 56.74 | |
529.65 | 10,981.12 | 57.79 | 1,645.85 | 22.25 | 185 | 74.66 | 53.07 | |
541.35 | 8,616.41 | 50.44 | 846.00 | 20.48 | 163 | #1 125.46 | 75.04 | |
665.05 | 6,673.16 | 88.26 | 998.85 | 29.74 | 62 | 22.09 | 65.09 | |
535.50 | 1,737.09 | 17.62 | 772.77 | 4.05 | 106 | 101.45 | 35.43 | |
275.70 | 1,435.87 | 45.95 | 310.41 | 21.30 | 34 | -13.89 | 41.31 | |
569.60 | 1,113.14 | #1 15.30 | 498.18 | #1 237.06 | 69 | 65.45 | 65.58 | |
1,154.40 | 990.78 | 16.05 | 141.92 | 27.17 | 61 | 22.50 | 42.83 | |
300.55 | 956.06 | -675.56 | 1,319.27 | 12.68 | -3 | -173.86 | 54.40 |
Growth Rate
Revenue Growth
-18.87 %
Net Income Growth
-44.55 %
Cash Flow Change
-90.52 %
ROE
15.64 %
ROCE
20.65 %
EBITDA Margin (Avg.)
-26.11 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 7 | 16 | 20 | 22 | 25 | 25 | 30 | 31 | 31 | 30 | 30 |
| Fixed Assets | 3 | 14 | 15 | 17 | 17 | 15 | 15 | 23 | 23 | 21 | 20 |
| Current Assets | 1 | 2 | 3 | 5 | 7 | 3 | 5 | 6 | 6 | 6 | 5 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 1 | 1 | 9 | 1 | 1 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 4 | 2 | 4 | 5 | 7 | 9 | 5 | 7 | 7 | 8 | 0 |
| Total Equity & Liabilities | 7 | 16 | 20 | 22 | 25 | 25 | 30 | 31 | 31 | 30 | 30 |
| Current Liabilities | 0 | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Non Current Liabilities | 0 | 7 | 6 | 6 | 8 | 5 | 7 | 7 | 6 | 3 | 2 |
| Total Equity | 6 | 8 | 10 | 14 | 16 | 18 | 21 | 22 | 24 | 27 | 27 |
| Reserve & Surplus | 5 | 6 | 8 | 3 | 5 | 7 | 10 | 12 | 13 | 16 | 17 |
| Share Capital | 1 | 2 | 2 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 1 | 1 | -1 | 0 | -0 | 0 | -1 | 1 | 0 |
| Investing Activities | -3 | -8 | -3 | -2 | -1 | 2 | -11 | -1 | -1 | 4 |
| Operating Activities | 4 | 2 | 5 | 3 | 1 | 1 | 9 | 2 | 4 | 0 |
| Financing Activities | -0 | 6 | -1 | -2 | 0 | -3 | 2 | -1 | -2 | -4 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 73.84 % | 73.84 % | 73.84 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % | 73.83 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.58 % | 0.58 % | 0.28 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 23.43 % | 23.19 % | 23.01 % | 22.58 % | 23.04 % | 23.29 % | 22.27 % | 23.83 % | 22.72 % | 22.75 % | 23.00 % | 22.83 % | 22.21 % | 23.49 % | 23.84 % | 23.65 % | 23.58 % | 23.60 % | 23.73 % | 23.72 % | 23.58 % |
| Others | 2.73 % | 2.97 % | 3.15 % | 3.59 % | 3.13 % | 2.88 % | 3.90 % | 2.34 % | 3.45 % | 3.42 % | 2.58 % | 2.75 % | 3.68 % | 2.68 % | 2.33 % | 2.52 % | 2.58 % | 2.57 % | 2.44 % | 2.44 % | 2.59 % |
| No of Share Holders | 732 | 908 | 990 | 974 | 998 | 967 | 994 | 1,041 | 1,445 | 1,636 | 2,628 | 3,057 | 3,502 | 3,776 | 4,067 | 4,496 | 4,493 | 4,552 | 4,550 | 4,452 | 4,414 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 Apr 2018 |  Bonus | 36:10 | 26 Apr 2018 | 99.56 | 125.00 |
| 20 May 2023 |  Split | 5:10 | 19 Jul 2023 | 71.60 | 71.60 |
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 25.91 | 25.60 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 24.41 | 23.33 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 23.93 | 23.83 |
| 22 Feb 2025 |  Extraordinary General Meeting | NA | 22 Feb 2025 | 25.08 | 24.38 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 22.20 | 22.36 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 19.24 | 18.90 |
| 27 Sept 2025 | Annual General Meeting | NA | 27 Sept 2025 | 18.49 | 18.19 |
| 08 Nov 2025 | Quarterly Result Announcement | NA | 08 Nov 2025 | 17.49 | 17.20 |
| 07 Feb 2026 | Quarterly Result Announcement | NA | 07 Feb 2026 | 14.60 | 15.52 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 13.98 | 15.34 |
Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance9 days ago
9 days agoSubmission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026.9 days ago
9 days agoBoard Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30.9 days ago
9 days agoBoard Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015May 20, 2026
May 20, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2026
Apr 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 21, 2026
Apr 21, 2026Reply To The Clarification Sought By The Stock Exchange With Reference To The Significant Movement In Share Price Of The Securities Of The Company;Apr 09, 2026
Apr 09, 2026Clarification sought from Tejnaksh Healthcare LtdApr 08, 2026
Apr 08, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2025.Feb 07, 2026
Feb 07, 2026Board Meeting Outcome for Outcome Of Board Meeting In_Accordance With SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015 Held On 7Th Feb 2026Feb 07, 2026
Feb 07, 2026Board Meeting Intimation for 1. To Consider And Approve Un-Audited Financial Results (Standalone & Consolidated) For The
Quarter 31St December 2025.
2. Any Other Matter With The Permission Of The Chair.Feb 02, 2026
Feb 02, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 18, 2026
Jan 18, 2026Closure of Trading WindowDec 28, 2025
Dec 28, 2025Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2025Nov 08, 2025
Nov 08, 2025Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure
Requirements) Regulations 2015
Nov 08, 2025
Nov 08, 2025Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure
Of Trading WindowNov 02, 2025
Nov 02, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 19, 2025
Oct 19, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 28, 2025
Sep 28, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 28, 2025
Sep 28, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 28, 2025
Sep 28, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 24, 2025
Sep 24, 2025Intimation Of Book Closure And E-Voting Of The 18Th Annual General Meeting Of The Company.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Notice Of 18Th Annual General Meeting Of The Company To Be Held On 27Th September 2025Sep 05, 2025
Sep 05, 2025Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th June 2025.Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading WindowAug 06, 2025
Aug 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 26, 2025
Jul 26, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMay 29, 2025
May 29, 2025Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year Endon 31St March 2025.May 29, 2025
May 29, 2025Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30.May 29, 2025
May 29, 2025Board Meeting Intimation for Audited Result And Any Other Matter With The Permission Of Chair Under Regulation 29 Of SEBI (LODR) Regulations 2015May 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 19, 2025
May 19, 2025Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 28, 2025
Apr 28, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Apr 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 23, 2025
Apr 23, 2025Board Meeting Outcome for In Continuation Of Our Intimation For Outcome Of The Meeting Dated 15/04/2025 We Are Submitting A Draft Letter Of Offer Upto Rs. 725 Lakhs Approved By The Board Of Directors Of The Company At Their Meeting Held Today."Apr 15, 2025
Apr 15, 2025Board Meeting Outcome for Outcome Under Regulation 30 Of SEBI (Listing Obligation And Disclosure
Requirement) - Meeting Of The Board Of Directors Held On Tuesday April 15 2025 For Draft Letter Of OfferApr 15, 2025
Apr 15, 2025Board Meeting Intimation for Reschedule Of Meeting Of The Board Of Directors To Be Held On Tuesday April 15 2025 And Intimation Of Closure Of Trading WindowApr 12, 2025
Apr 12, 2025Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirement) -
Prior Intimation Of The Meeting Of The Board Of Directors To Be Held On Saturday April 12 2025
And Intimation Of Closure Of Trading WinApr 07, 2025
Apr 07, 2025Renewal Of DSIR Approval For Tejnaksh Healthcares Research LabApr 05, 2025
Apr 05, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 24, 2025
Feb 24, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMFeb 22, 2025
Feb 22, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2024.Feb 11, 2025
Feb 11, 2025Technical Indicators
RSI(14)
Neutral 46.44
ATR(14)
Less Volatile 0.92
STOCH(9,6)
Neutral 65.12
STOCH RSI(14)
Neutral 64.06
MACD(12,26)
Bearish -0.01
ADX(14)
Weak Trend 14.55
UO(9)
Bearish 49.93
ROC(12)
Uptrend And Accelerating 4.94
WillR(14)
Neutral -44.98
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
